/daily ·26 OCT 2026 ·MONDAY ·2 MIN READ ·6 STORIES

The day in AI

01 / The Day

MONDAY 26 OCT 2026, ranked

ASPREE Sub-Study: Aspirin Linked to 70% Lower Dementia Risk by Genotype

A pharmacogenomic sub-analysis of 13,500 ASPREE trial participants found that daily low-dose aspirin reduced relative dementia risk by 70% specifically in older adults carrying certain platelet-associated genetic variants.

Effect was genotype-specific — not observed across the overall unselected cohort
Analysis used data from 13,500 participants in the long-running ASPREE trial
Mechanism may involve aspirin anti-platelet effects on cerebrovascular microthrombi

Why it mattersGenetic stratification of aspirin effects signals that population-level trial results can mask strong subgroup benefits — a model for precision prevention research.

01 sciencedaily.com↗

Study: Mediterranean Diet Elevates Mitochondrial Longevity Peptides

A study found adherence to a Mediterranean diet significantly elevates circulating levels of the mitochondrial-derived peptides humanin and SHMOOSE, revealing a direct molecular pathway linking dietary pattern to cardiovascular and neurodegenerative protection.

Humanin and SHMOOSE are encoded in mitochondrial DNA and decline with advancing age
Diet-driven peptide elevation provides a molecular explanation for Mediterranean diet benefits
Both peptides are under active investigation as longevity biomarkers and therapeutic targets

Why it mattersIdentifying a specific molecular intermediary between diet and longevity shifts Mediterranean diet research from epidemiology to mechanistic biology.

02 sciencedaily.com↗

Taurine Suppresses Age-Related Inflammaging via Innate Immune Pathway

Yale researchers found that taurine regulates how innate immune cells detect endogenous damage-associated molecular patterns, with sustained taurine levels suppressing the chronic systemic inflammation characteristic of biological aging.

Taurine modulates DAMP pattern recognition — endogenous danger signals that accumulate with age
Effect demonstrated in cell culture and aged animal models
Taurine is a naturally occurring amino acid whose circulating levels decline with age

Why it mattersMapping a specific molecular control point for inflammaging positions taurine signalling as a tractable target for drugs modulating the ageing immune system.

03 medicine.yale.edu↗

Abemaciclib Suppresses Senescent Cell Inflammation in Aged-Mice Study

Short-term CDK4/6 inhibition using the cancer drug abemaciclib selectively suppressed the pro-inflammatory SASP component of cellular senescence and improved physical performance in aged mice without requiring cytotoxic cell ablation.

Abemaciclib is FDA-approved for breast cancer, here re-tested as a senomorphic agent
Targeted the CDK4/6-RARa-NF-kB axis to reduce inflammatory SASP signalling
Aged mice showed improved systemic physical performance without cell-killing

Why it mattersA senomorphic effect from a drug already approved in humans accelerates the path to clinical testing compared to novel senolytic compounds requiring full safety profiling.

04 doi.org↗

Direct Reprogramming Rolls Back Neural Epigenetic Age Over 60 Years

Researchers converted blood precursor cells from an 80-year-old donor directly into neural stem cells, rolling back epigenetic clock signatures by more than 60 years while bypassing the pluripotent stem cell stage to avoid oncogenic risk.

Epigenetic age reduced by over 60 years on DNA methylation clocks
Direct lineage conversion bypasses the iPSC stage, reducing teratoma formation risk
Demonstrates stepwise, traceable epigenetic rejuvenation in human neural tissue

Why it mattersDemonstrating safe epigenetic rejuvenation in human neural cells without pluripotency-induced oncogenic risk clears a major conceptual barrier for partial reprogramming research.

05 doi.org↗

Human Study: Autophagy Does Not Universally Decline with Aging

A study in Aging Cell challenges the prevailing assumption that autophagy uniformly decreases with age, finding autophagic flux varies substantially by cell type and sex, with elevated autophagy in specific aging cell populations linked to reduced physical function.

Autophagic flux was elevated, not reduced, in certain aging immune cell subsets
Variation was significant between sexes and across distinct cell types studied
Links to physical function decline suggest cell-type-specific autophagy targets for geroscience

Why it mattersIf autophagy regulation is cell-type and sex-specific, blanket autophagy-enhancing strategies may produce opposing effects in different tissues — a finding with major therapeutic implications.

06 onlinelibrary.wiley.com↗

Be subscriber #022 the weekly ten, every friday by email · no spam · unsubscribe anytime

Past days

The Daily Archive

/FRI 30 OCTFour Aging Mechanisms, All Fresh /WED 28 OCTWednesday: Bone Mechanics, Zombie Cells, and a Triple Agonist /MON 26 OCT2026-10-26 /FRI 23 OCTSignals, Clearance, and Clock Caveats /WED 21 OCTWednesday: Reprogramming Reaches Humans, Lifespan Extends in Mice /MON 19 OCTCentenarian Signatures /FRI 16 OCTMuscles, Autophagy, and the Peptide Policy Push /WED 14 OCTCysteine, Centenarians, and Senescent Discs /MON 12 OCTT cells, lipids, and the gut-brain aging axis /FRI 09 OCTClocks, Genomes, and Repair /WED 07 OCTThe Long Lipid Edition /MON 05 OCTMonday Deep Reads /FRI 02 OCTFriday in Longevity: AMPK delivers, FDA maps the path /WED 30 SEPTTau tangles, mTOR complexity, and ultraprocessed food /MON 28 SEPTMitochondria, Dendritic Cells, and the Case for Creatine /WED 23 SEPTAging's Molecular Clock: Six Studies That Move the Field /MON 21 SEPTGLP-1 clears the aging bar; a new immune evasion mechanism in senescent cells /FRI 18 SEPTThe calorie clock, the muscle leak, and the microprotein atlas /WED 16 SEPTTwo New Senescence Targets, Brain Clocks, and Cancer's Age Connection /MON 14 SEPTThe SASP Dial /FRI 11 SEPTThe Senolytic Score